Maria R. Gaiser
Expertise in
1
conditions

Maria R. Gaiser

Heidelberg, BW, DE 
Expertise in
1
conditions
Heidelberg, BW, DE 

Overview

Maria Gaiser practices practicing medicine in Heidelberg, Germany.

Ms. Gaiser is highly rated in 1 condition, according to our data. Her clinical expertise encompasses Merkel Cell Carcinoma, Neuroendocrine Tumor, Melanoma, and Acrokeratoelastoidosis of Costa.

She is actively involved in clinical research, co-authoring 27 peer reviewed articles and participating in 1 clinical trial.

Gender

Female

Locations

Heidelberg, BW 69120, Germany
Other Locations
Mannheim, BW, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase II, Open-label, Randomized-controlled Trial Evaluating the Efficacy and Safety of a Sequencing Schedule of Cobimetinib Plus Vemurafenib Followed by Immunotherapy With an Anti- PD-L1 Antibody Atezolizumab for the Treatment in Patients With Unresectable or Metastatic BRAF V600 Mutant Melanoma
A Phase II, Open-label, Randomized-controlled Trial Evaluating the Efficacy and Safety of a Sequencing Schedule of Cobimetinib Plus Vemurafenib Followed by Immunotherapy With an Anti- PD-L1 Antibody Atezolizumab for the Treatment in Patients With Unresectable or Metastatic BRAF V600 Mutant Melanoma
Enrollment Status: Completed
Publish Date: April 09, 2025
Intervention Type: Drug
Study Drugs: Vemurafenib, Cobimetinib, Atezolizumab
Study Phase: Phase 2

27 Total Publications

ATOH1, TFAP2B, and CEACAM6 as Immunohistochemical Markers to Distinguish Merkel Cell Carcinoma and Small Cell Lung Cancer.
ATOH1, TFAP2B, and CEACAM6 as Immunohistochemical Markers to Distinguish Merkel Cell Carcinoma and Small Cell Lung Cancer.
Journal: Cancers
Published: December 30, 2023

Frequently Asked Questions about Maria R. Gaiser

Is Maria R. Gaiser a top-rated expert for Merkel Cell Carcinoma?

MediFind is an objective health platform that identifies experts based on real-world data. Maria R. Gaiser is classified as an Advanced expert for Merkel Cell Carcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Maria R. Gaiser participate in research or clinical trials?

Yes. Maria R. Gaiser has published 27 articles and abstracts on conditions like Merkel Cell Carcinoma. You can view a list of Maria R. Gaiser's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Gaiser's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile